← Back
$SER All transactions

Serina Therapeutics, Inc.

A

$ Value

$0

Shares

69,000

Price

$0

Filed

Feb 17

Insider

Name

Tenjarla Srini

Title

SVP, CMC & Formulation

CIK

0002029985

Roles

Officer

Transaction Details

Transaction Date

2026-02-03

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

69,000

Footnotes

Unless otherwise terminated as provided in the optionee's option agreement, 12/48ths of the shares subject to the option shall vest twelve months after the Vesting Commencement Date, and 1/48th of the shares subject to the option shall vest on the same calendar day of each subsequent month thereafter until the shares subject to the option are fully vested.

Filing Info

Accession No.

0002029985-26-000002

Form Type

4

Issuer CIK

0001708599

Tenjarla Srini's History

Date Ticker Type Value
2026-02-03 SER A $0

Other Insiders at SER (90d)

Insider Bought Sold Last
LEDGER STEVEN A
Chief Executive Officer
2026-02-03
GILL SIMBA 2026-02-03
Moreadith Randall
Chief Scientific Officer
$159K 2026-03-23
Bailey Gregory 2026-03-31
Venkatesan Jay 2026-03-31